AA
ASBP

AQR Arbitrage’s Aspire Biopharma ASBP Stock Holding History

AQR Arbitrage’s Portfolio ASBP Stock Details ASBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-125
Closed -$1.65M – 600
2024
Q1 		$1.65M Hold
125
– – 0.06% 252
2023
Q4 		$1.64M Hold
125
– – 0.07% 265
2023
Q3 		$1.62M Hold
125
– – 0.07% 266
2023
Q2 		$1.57M Sell
125
-578
-82% -$7.26M 0.07% 289
2023
Q1 		$8.85M Sell
703
-36
-5% -$450K 0.27% 107
2022
Q4 		$9.14M Hold
739
– – 0.23% 121
2022
Q3 		$8.99M Sell
739
-378
-34% -$4.56M 0.2% 126
2022
Q2 		$13.4M Buy
+1,117
New +$13.4M 0.3% 81

Other funds holding ASBP

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AQR Arbitrage's ASBP Position: Q2 2024 in Review

AQR Arbitrage sold out of Aspire Biopharma (ASBP) in Q2 2024, closing a stake of 125 shares — an estimated $1.65M sold.

AQR Arbitrage first reported a position in ASBP in Q2 2022 and held it in 8 quarters. The position peaked at $13.4M in Q2 2022. 3 funds tracked by Wall St. Rank hold ASBP as of Q2 2024.

  • AQR Arbitrage reported no remaining Aspire Biopharma position as of Q2 2024 after selling out during the quarter.
  • AQR Arbitrage sold 125 Aspire Biopharma shares in Q2 2024, an estimated $1.65M.
  • AQR Arbitrage first reported a position in Aspire Biopharma in Q2 2022 and held it in 8 quarters.
  • AQR Arbitrage's Aspire Biopharma position peaked at $13.4M in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Aspire Biopharma as of Q2 2024.

Based on AQR Arbitrage's 13F filing for Q2 2024, filed 14 Aug 2024.